In high-risk patients, we found elevated levels of gene signatures for CD8+ T cells, CD4+ T cells, dendritic cells, and macrophages, suggesting augmented immune cell infiltration in the tumor, a characteristic of a more inflammatory tumor microenvironment and potential immunosuppression. The gene discussed is CD8A; the disease is neoplasm.